Partnership Limited GP Biofund Israel Orbimed Novus Therapeutics, Inc

As of December 4, 2020

Partnership Limited GP Biofund Israel Orbimed Net Worth

• Net worth is estimated to be at least $60.53M
• Owns at least 73,650 units of Novus Therapeutics, Inc stock
• Sold an estimated value of $2.23M in the last 3 years at Novus Therapeutics, Inc

Partnership Limited GP Biofund Israel Orbimed Trading

• Largest purchase of shares was 646,204 units , worth over $2M on May 6, 2019
• Largest sale of shares was 103,200 units , worth over $2.23M on December 4, 2020
• In total has made about 4 transactions over 3 years
• Usually trades in May, with the busiest year in 2020

Partnership Limited GP Biofund Israel Orbimed Mailing Address

• Mailing address is 601 Lexington Avenue, 54th Floor New York NY 1022-4629 NY

Novus Therapeutics, Inc Insider Trading

• The most recent transaction was 103,200 units sold on December 4, 2020 by Orbimed Israel GP Ltd and Partnership Limited GP Biofund Israel Orbimed worth over $2.23M
• In the last 3 years, insiders at Novus Therapeutics, Inc sold an estimated value of $2.63M and bought an estimated value of $7.31M
• The most active traders are Catherine C Turkel, President,  Gregory J Flesher, Chief Executive Officer,  and Jon Kuwahara, See Remarks
• Insider trading is most common in May, with the busiest year in 2019